Schaumberg et al. [56] used a group of 177 patients diagnosed with prostate cancer from the TCGA, 20 of them had mutant speckle-type POZ protein (SPOP), to train several groups of the CNN model to determine whether a mutation occurred in the SPOP gene of prostate cancer or not. This evidence concerns the gene SPOP and prostate carcinoma.